TMX Newsfile·2026-02-22 21:16Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities between February 26, 2025, and August 4, 2025, about the March 2, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 2, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation [4]. Group 3: Case Allegations - The lawsuit alleges that defendants made false or misleading statements and failed to disclose critical information regarding agilon's financial guidance for 2025, which was deemed unachievable due to known industry challenges [5]. - It is claimed that defendants overstated the positive financial impact of strategic actions taken by agilon, leading to materially false statements about the company's business and prospects [5]. - The lawsuit asserts that when the true information became public, investors suffered damages as a result [5].